The lysis of bacterial cells is an important step in biopharmaceutical production processes. To help you achieve consistent, high yields from your therapeutic protein production process, Merck Millipore offers a set of lysozymes that now includes CellPrime® recombinant human lysozyme (rLysozyme).
Specifically designed for use in biopharmaceutical production processes and life science research, CellPrime® rLysozyme is a powerful recombinant enzyme that exhibits a 3.4 fold higher specific activity than the enzyme prepared from chicken egg white. Since CellPrime® recombinant human lysozyme is of non-animal origin, it also eliminates the risk of infectious disease transmission. CellPrime® recombinant human lysozyme is available in various pack sizes, including bulk amounts suitable for use in large scale processing.